Skip to main content
Top
Published in: Breast Cancer Research 1/2013

01-11-2013 | Oral presentation

4.5: Diagnosing breast cancer in a high-risk cohort

Authors: EAM O'Flynn, V Houle, ARM Wilson, AZ Evans, SD Allen

Published in: Breast Cancer Research | Special Issue 1/2013

Login to get access

Excerpt

MRI is a common method for detecting breast cancer in women at high risk [1, 2] These women may instead be diagnosed mammographically or present symptomatically. The aim of this study was to investigate how breast cancer is diagnosed in high-risk women and determine whether there are specific characteristics related to the type of presentation. …
Literature
Metadata
Title
4.5: Diagnosing breast cancer in a high-risk cohort
Authors
EAM O'Flynn
V Houle
ARM Wilson
AZ Evans
SD Allen
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3501

Other articles of this Special Issue 1/2013

Breast Cancer Research 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine